We reported the prevalence of autoantibodies against ganglionic acetylcholine receptor in GBS.
Sera from GBS patients in Japan were tested with luciferase immunoprecipitation systems (LIPS).
11.2% (9 of 80) of the sera samples from patients with GBS were positive for autoantibodies.
The anti-gAChR antibodies could mediate the autonomic dysfunction involved in the mechanisms of GBS.